Simplifying stroke risk stratification in atrial fibrillation patients: implications of the CHA2DS2–VASc risk stratification scores

Atrial fibrillation (AF) is a major risk factor for stroke and thromboembolism but this risk is not homogeneous among patients with AF, being dependent upon associated risk factors such as advancing age, hypertension, congestive heart failure, prior stroke, diabetes mellitus and structural heart dis...

Full description

Saved in:
Bibliographic Details
Published in:Age and ageing 2010-09, Vol.39 (5), p.533-535
Main Authors: Pamukcu, Burak, Lip, Gregory Y. H., Lane, Deirdre A.
Format: Article
Language:English
Subjects:
Aged
Aging
Atrial fibrillation
Atrial Fibrillation - drug therapy
Atrial Fibrillation - epidemiology
Fibrinolytic Agents - therapeutic use
Humans
Hypertension
Risk Assessment - methods
Risk Factors
Stratification
Stroke - epidemiology
Stroke - prevention & control
Strokes
Warfarin
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Atrial fibrillation (AF) is a major risk factor for stroke and thromboembolism but this risk is not homogeneous among patients with AF, being dependent upon associated risk factors such as advancing age, hypertension, congestive heart failure, prior stroke, diabetes mellitus and structural heart disease (1). Current guidelines (2-4) recommend warfarin for those at high risk, aspirin for low risk and 'either aspirin or warfarin' for those at intermediate risk. Based on stroke risk factors, many risk stratification schemas have been developed in order to categorise a patient's risk of stroke and aid decision regarding the most appropriate thromboprophylaxis. Adapted from the source document.
ISSN:0002-0729
1468-2834
DOI:10.1093/ageing/afq059